Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2850
+0.0030 (1.06%)
At close: Oct 8, 2025, 4:00 PM EDT
0.2801
-0.0049 (-1.72%)
After-hours: Oct 8, 2025, 7:56 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.98 million as of October 8, 2025. Its market cap has decreased by -74.62% in one year.
Market Cap
13.98M
Enterprise Value
11.89M
1-Year Change
-74.62%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.98M, a decrease of -78.82%. That is a compound annual growth rate of -49.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 13.98M | -47.41% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |